A phase II open-label, single-centre, non-randomized trial of Y90 transarterial radioembolization in combination with nivolumab in Asian patients with intermediate stage hepatocellular carcinoma: An immunological study of radioembolization in combination with anti-PD1 therapy in HCC.
Year: 2018
Type: conference-abstract
Source: Journal of Clinical Oncology
Authors: Esther Wei Yin Chang, David Wai-Meng Tai, Si-Lin Koo, Matthew CH Ng, Joe Poh Sheng Yeong, Wei Wei Zhai, Evan Newell, Pierce K. H. Chow, Kiat Hon Lim, Apoorva Gogna, Aaron Kian Ti Tong, Hian Liang Huang, Kelvin Siu Hoong Loke, David Chee Eng Ng, Tiffany Priyanthi Hennedige, Choon Hua Thng, Su Pin Choo
Language: English
Subfield: Hepatology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W2806300407